Seminars in Diagnostic Pathology
Volume 29, Issue 1 , Pages 12-18 , February 2012

Acute leukemias of ambiguous lineage

  • Marie C. Béné, PharmSciD, PhD

      Affiliations

    • Laboratoire d'Immunologie du CHU and Nancy Université, Vandœuvre lès Nancy, France
  • ,
  • Anna Porwit, MD, PhD

      Affiliations

    • Department of Laboratory Hematology, University Health Network, Toronto, Ontario, Canada
    • Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
    • Corresponding Author InformationAddress reprint requests and correspondence: Anna Porwit, MD, PhD, Department of Laboratory Hematology, Toronto General Hospital, University Health Network, 11th Floor, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada

  • Image Result

    Example of the usefulness for lineage assignment of the combination myeloperoxidase (MPO), cCD13, cCD3, and cCD79a on a permeabilized sample of normal whole bone marrow (A–K) and a leukemic sample (L)

    Example of the usefulness for lineage assignment of the combination myeloperoxidase (MPO), cCD13, cCD3, and cCD79a on a permeabilized sample of normal whole bone marrow (A–K) and a leukemic sample (L). Color code: red, polymorphonuclears; green, monocytes; purple, lymphocytes; cyan, immature cells defined as “not polymorphonuclears, not monocytes, not lymphocytes,” called the “bermudes” area by the GTLLF.27 (A) Whole populations on a side scatter/CD45 “cartography” scattergram. (B) Whole populations on an MPO/cCD13 scattergram. (C) Whole populations on an MPO/cCD3 scattergram. (D) Whole populations on an MPO/cCD13 scattergram. (E) Polymorphonuclear gating of the MPO/cCD13 scattergram showing MPO gradient of expression. (F) Monocyte gating of the MPO/cCD13 scattergram showing weak MPPO labeling. (G) Lymphocyte gating of the MPO/cCD3 scattergram showing MPO-negative cCD3-positive T cells. (H) Lymphocyte gating of the MPO/cCD79a scattergram showing MPO-negative cCD79a-positive B cells. (I) Bermudes gating of the MPO/cCD79a scattergram showing hematogones. (J) Gating of the hematogones population in dark blue. (K) Backgating of the hematogones defined in J on the initial “cartography” scattergram. The same strategy would be used to identify the blastic population in a leukemic sample as shown in L for MPO positivity backgating. Mixed phenotype acute leukemia would show the coexpression of markers of different lineages such as cCD79 and MPO or cCD3 and MPO.

  • Image Result
    Example of a case of T/myeloid mixed phenotype acute leukemia. The 4 top scattergrams show the same combinations as in Figure 1. There is large population of blasts in the “bermudes” area, very few ne

    Example of a case of T/myeloid mixed phenotype acute leukemia. The 4 top scattergrams show the same combinations as in Figure 1. There is large population of blasts in the “bermudes” area, very few neutrophils, almost no monocytes, and a normal amount of lymphocytes. The latter mostly express CD79a. The blastic population coexpresses myeloperoxidase (with a spreading pattern) and cyt.CD3 as highlighted in the backgating illustrated in the middle panels. In another tube, these cells are shown to coexpress CD34 and faintly CD13 (bottom scattergram).

  • Image Result
    Example of mixed phenotype acute leukemia, not otherwise specified, T/myeloid diagnosed in immunochemistry. The material studied was a mediastinal biopsy from a young male patient. It was received for

    Example of mixed phenotype acute leukemia, not otherwise specified, T/myeloid diagnosed in immunochemistry. The material studied was a mediastinal biopsy from a young male patient. It was received formalin fixed. Immunostainings showed a diffuse infiltration of blasts with strong positivity for CD7, variable expression of CD3, weak positivity for CD33, and a fraction of blasts positive for myeloperoxidase. The blast population was also positive for TdT, CD2, and CD5 (weaker than normal T cells), as well as partly for CD117 and CD123 (not shown). There was some positivity for CD79a, which may be seen in some T lineage acute lymphoblastic leukemia. CD34, PAX-5, CD10, CD4, CD8, and CD1a were negative. A similar immunophenotype was found in a bone marrow biopsy that was diffusely infiltrated by blasts. There was no peripheral blood involvement. Cytogenetic studies showed a hyperdiploid karyotype.

PII: S0740-2570(11)00103-1

doi: 10.1053/j.semdp.2011.08.004

Seminars in Diagnostic Pathology
Volume 29, Issue 1 , Pages 12-18 , February 2012